ARTICLE | Company News
VGNX, GeneMatrix pharmacogenomics deal
December 20, 2001 8:00 AM UTC
Variagenics (VGNX) and GeneMatrix (Seoul, Korea) will develop molecular diagnostics to predict patient responses to colon and gastric cancer therapeutics. GeneMatrix will receive access to VGNX's SNP ...